Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Q: What does CUSIP 74065P101 represent in this 13F holders report?

CUSIP 74065P101 is the security identifier for PRLD - Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held PRLD - Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share in Q4 2023?

55 institutional investors reported PRLD - Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 74065P101

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 34,725,223
Total 13F value: $148,268,893
Share change: -1,888,986
Put/Call ratio: 143%
SEC-reported price per share: $4.27
Number of holders: 55
Value change: -$6,317,081
Number of buys: 34
Number of sells: 22
Shares outstanding: 64,968,808

Security key

74065P101

Report period

Q4 2023

Institutions

Top holders

PRLD full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Prelude Therapeutics Inc SEC filings Prelude Therapeutics Inc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 74065P101

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q3 2025

Ownership snapshot

Top reported holders of PRLD - Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

30 Sep 2023

13F Highest disclosed value: $33,709,601 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $33.71M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $33.71M

BAKER BROS. ADVISORS LP $31.28M

Boxer Capital, LLC $7.71M

EcoR1 Capital, LLC $3.58M

BlackRock Finance, Inc. $3.3M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$33,709,601 10,909,256 shares	—	30 Sep 2023
BAKER BROS. ADVISORS LP	13F Company 13F	— denominator unverified	$31,282,616 10,123,824 shares	—	30 Sep 2023
Boxer Capital, LLC	13F Company 13F	— denominator unverified	$7,709,606 2,495,018 shares	—	30 Sep 2023
EcoR1 Capital, LLC	13F Company 13F	— denominator unverified	$3,576,527 1,157,452 shares	—	30 Sep 2023
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$3,301,460 1,068,434 shares	—	30 Sep 2023
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	— denominator unverified	$3,298,000 1,066,858 shares	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

34,725,223

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2023 holders

Holder diff

Investor	Q3 2025 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2025 value	Q4 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend